# A Clinical Trial to Compare Forms of MK-1167 in Healthy People (MK-1167-011)

> **NCT07334860** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 16 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** MK-1167

## Key facts

- **NCT ID:** NCT07334860
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-02-06
- **Primary completion:** 2026-05-28
- **Final completion:** 2026-05-28
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07334860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07334860, "A Clinical Trial to Compare Forms of MK-1167 in Healthy People (MK-1167-011)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07334860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*